Anyong Xie

机构：Sir Run Run Shaw Hospital, Zhejiang Cancer Hospital, Zhejiang University · ORCID：0000-0002-6608-2550

发表论文 74 篇 · 总被引 3146 次 · h-index 27

代表论文

• Target residence of Cas9-sgRNA influences DNA double-strand break repair pathway choices in CRISPR/Cas9 genome editing (2022 · Genome biology · 被引 41)
• DNA nicks induce mutational signatures associated with BRCA1 deficiency (2022 · Nature Communications · 被引 31)
• Small extrachromosomal circular DNA harboring targeted tumor suppressor gene mutations supports intratumor heterogeneity in mouse liver cancer induced by multiplexed CRISPR/Cas9 (2023 · Genome Medicine · 被引 11)
• Proximal binding of dCas9 at a DNA double strand break stimulates homology-directed repair as a local inhibitor of classical non-homologous end joining (2023 · Nucleic Acids Research · 被引 10)
• Disruption of DNA-PKcs-mediated cGAS retention on damaged chromatin potentiates DNA damage-inducing agent-induced anti-multiple myeloma activity (2024 · British Journal of Cancer · 被引 9)
• TREX2 enables efficient genome disruption mediated by paired CRISPR-Cas9 nickases that generate 3′-overhanging ends (2023 · Molecular Therapy — Nucleic Acids · 被引 8)